Tag archive for ‘UK-Israeli High-Tech Hub biomed’
Gali Weinreb On Monday, February 17th, 2014

GSK And Technion Sign Drug Development Deal

– GlaxoSmithKline and BioRap will commercialize a treatment for lethal side effects of bone marrow transplants. – – Pharmaceutical giant GlaxoSmithKline plc (LSE: GSK) has signed a joint More...

Wordpress site Developed by Fixing WordPress Problems